Cite
HARVARD Citation
Tao, Y. et al. (2023). A Randomized, Open‐Label, Phase I Clinical Study of Dalpiciclib With Different Specifications After Process Modification in Healthy Chinese Volunteers. Clinical pharmacology in drug development. 12 (1), pp. 65-69. [Online].